Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for March 24, 2011 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



GenScript will launch services with GANP technology for World Wide market excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP mice from TransGenic Inc. to produce high-affinity antibodies 
x-small text small text medium text large text


    PISCATAWAY, NJ, March 24, 2011 /24-7PressRelease/ -- GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP mice from TransGenic Inc. to produce high-affinity antibodies to scientists.

GANP (Germinal Center Associated Nuclear Protein) is a protein discovered by Dr. Nobuo Sakaguchi at Kumamoto University to be over-expressed in B-cells centered in embryo. Research suggested that GANP is important in the reconstruction of antibody genes. Transgenic mice which express high level of GANP can be used to produce antibodies with a high affinity.

"This technology will tremendously improve the quality of our antibody products in terms of specificity, affinity and epitope diversity." commented David Chang, director of GenScript's Antibody Department.

GenScript has developed a state-of-the-art antibody production platform to meet different customers' needs, including OptimumAntigenTM design tool, T-MaxTM adjuvant, and nanotechnology for antigen preparation. Her animal facility was accredited by AAALAC and OLAW. With access to GANP Mouse Technology, antibodies generated from GenScript can potentially be used for diagnostic and therapeutic purposes because of higher affinity and higher specificity.

About GenScript Corporation

GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.

For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA Inc.
1-(732) 885-9188
Source: http://www.genscript.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Yunfan Li:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Yunfan Li
GenScript

Marketing Department
120 Centennial Ave.
Piscataway,, New Jersey
Unites States 08854
Voice: 877-4367274
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.